Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MICRO trial: Methylphenidate for fatigue in haematological cancer
2017-001844-36Phase 3Completed
- Sponsor
- University Hospital Odense
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of methylphenidate in cancer-related fatigue (CRF), myalgic encephalomyelitis (ME) and hematopoietic malignancies (2 arms), sponsored by University Hospital Odense. Primary endpoint: Primary end-point. Started Jun 2017; status: completed.
02
Drugs
methylphenidate
03
Conditions
cancer-related fatigue (CRF)myalgic encephalomyelitis (ME)hematopoietic malignancies
Beyond the preview
Go deeper on 2017-001844-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001844-36.